2008-June Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Sun Jun 1 13:24:08 2008
Ending: Mon Jun 30 12:56:02 2008
Messages: 100

• [Ip-health] AP: Sen. McCain offers $300 million prize for new auto battery   Malini Aisola
• [Ip-health] text of WHA resolution on PH, Innovation & IP?   Amy Nunn, ScD
• [Ip-health] Livemint India: Draft WHO pact on drugs cheered by India   Thiru Balasubramaniam
• [Ip-health] ACTA meeting (June 3-4) in Geneva: Query for information   Thiru Balasubramaniam
• [Ip-health] ars technica: The real ACTA threat (it's not iPod-scanning border guards)   Thiru Balasubramaniam
• [Ip-health] Views on the 61st World Health Assembly adoption of Global Strategy on Public Health, Innovation and Intellectual Property   Thiru Balasubramaniam
• [Ip-health] Oxfam and MSF letters to the editor in the IHT: Drugs for developing countries   Thiru Balasubramaniam
• [Ip-health] EU TRADE NEWS: Anti-Counterfeiting Trade Agreement (ACTA) - Statement following meeting in Geneva   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Speculation Persists On ACTA As First Official Meeting Concludes   Thiru Balasubramaniam
• [Ip-health] WHA61.21: Global strategy and plan of action on public health, innovation and intellectual property   Thiru Balasubramaniam
• [Ip-health] Michael Geist in the Star: Transparency needed on ACTA   Thiru Balasubramaniam
• [Ip-health] Wall Street Journal: High Court Further Limits Scope of Patents   Thiru Balasubramaniam
• [Ip-health] Associated Press and Financial Times on Brazil/US cotton case and its ramifications on trademarks and patents   Thiru Balasubramaniam
• [Ip-health] Financial Times: Japan's Daiichi pays $4.6 billion for Ranbaxy   Thiru Balasubramaniam
• [Ip-health] Provisional Programme and Registration for Access to Knowledge 3 Conference in Geneva (8-10 Sept 2008)   Thiru Balasubramaniam
• [Ip-health] Financial Times (Lex column): Generic tastes   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Standing Committee On The Law Of Patents To Reconvene After Two Year Hiatus   Thiru Balasubramaniam
• [Ip-health] Chilean official takes helm of WIPO patent committee   Thiru Balasubramaniam
• [Ip-health] James Love's post in Huffington Post: A few important stories that are not news (in the US)   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Member Nations Balk at World Customs Organization IP Enforcement Push   Thiru Balasubramaniam
• [Ip-health] WIPO patent committee embarks on positive agenda   Thiru Balasubramaniam
• [Ip-health] Spain Becomes a Major Government Funder of MMV   Jaya Banerji
• [Ip-health] Fwd: TAC complaint increases access to efavirenz: MSD finally agrees to grant licenses on reasonable terms   Jonathan Berger
• [Ip-health] Fwd: DFID e-bulletin: Civil Society Challenge Fund   Michelle Childs
• [Ip-health] Congressional Briefing: Improving Antimalarial Drug Quality in Africa   Philip Coticelli
• [Ip-health] second edition of WHO/HAI price measurement manual available   Marg Ewen
• [Ip-health] Consumers defend Vt prescription privacy law   Sean Flynn
• [Ip-health] Malaria: a miracle in the making offers hope to millions worldwide   Ira Glazer
• [Ip-health] Re: [A2k] EU TRADE NEWS: Anti-Counterfeiting Trade Agreement (ACTA) - Statement following meeting in Geneva   Robin Gross
• [Ip-health] UN overstated Aids risk, says specialist [Observer, UK]   Julian Harris
• [Ip-health] Wanted: Information About Patents/Licensing of Basic Molecular Biology Reagents and Methods   Biotech. Info. Inst.
• [Ip-health] CL trade-off feared at talks   Kannikar KIJTIWATCHAKUL
• [Ip-health] Thailand: Cheap heart drug arrives from India   Kannikar KIJTIWATCHAKUL
• [Ip-health] Court orders reinstatement of GPO board   Kannikar KIJTIWATCHAKUL
• [Ip-health] Ranbaxy buy may hit generic drugs supply   Gopa Kumar
• [Ip-health] Vietnam's IP Law question   GRAIN LB
• [Ip-health] Brazil introduced an opposition to a patent on an Aids medicine   MSF Michel Lotrowska
• [Ip-health] Congress tries to get Israel off of US intellectual property blacklist   James Love
• [Ip-health] Pharma Anti-Counterfeiting Conference, 30th June-2nd July, London   James Love
• [Ip-health] Congressional Briefing: Improving Antimalarial Drug Quality in Africa   James Love
• [Ip-health] Congressional Briefing: Improving Antimalarial Drug Quality in Africa   James Love
• [Ip-health] Fred Lohmann on Quanta v LG   James Love
• [Ip-health] Correspondence: EC/Peter Mandelson on Thail compulsory licensing dispute   James Love
• [Ip-health] KEI Statement at beginning of WIPO SCP   James Love
• [Ip-health] KEI Statement on patents and standards   James Love
• [Ip-health] Shamnad Basheer: Is the Indian Drug Controller Participating in the ACTA Negotiations?   James Love
• [Ip-health] EFPIAM seeks EU Repackaging ban, consequences for counterfiets, but also parallel trade in EU   James Love
• [Ip-health] House Ways and Means Democrats: USTR MUST STRIKE BALANCE BETWEEN PATENT AND PUBLIC HEALTH IN TRADE NEGOTIATIONS   James Love
• [Ip-health] WIPO SCP 12th session: Summary by the Chair   James Love
• [Ip-health] Global Upward IP Ratchet, Anti-Countefeiting and Piracy Enforcement Efforts - A New Paper by Susan Sell   Sisule F. Musungu
• [Ip-health] University Facilities for Developing Country Program   David Opderbeck
• [Ip-health] MSD licenses generic efavirenz in South Africa - was facing competition commission challenge   Mike Palmedo
• [Ip-health] Drug Makers Differ Strongly in Policies for Low-income Countries: Index lets investors select most socially responsible producers   Mike Palmedo
• [Ip-health] BNA: House Members Receive Feedback on Creating Follow-On Biologics Pathway   Mike Palmedo
• [Ip-health] WSJ: WiMAX Patent Pool Is Planned - Firms Aim to Spur Use by Limiting Royalty Payments   Matt Price
• [Ip-health] Drug Makers Differ Strongly in Policies for Low-income Countries   Matt Price
• [Ip-health] STEM Newsletter July 2008, Vol 3 No 2   Prabhu Ram
• [Ip-health] New website: Global Health Progress   Joana Ramos
• [Ip-health] Alert: BC Pharmaceutical Task Force Recommends replacing Therapeutics Initiative.   Joana Ramos
• [Ip-health] Lawsuit Over Right to DTC in Canada   Joana Ramos
• [Ip-health] =?windows-1252?Q?Global_Pharmaceutical_Markets_and_Corpo?= =?windows-1252?Q?rate_Citizenship=3A_The_Case_of_Novartis=92_?= =?windows-1252?Q?Anti-cancer_Drug_Glivec?=   Joana Ramos
• [Ip-health] Medicare Savings vs. the Lobbyists   Joana Ramos
• [Ip-health] Gene Testing Questioned by Regulators   Joana Ramos
• [Ip-health] Key opinion leaders: independent experts or drug representatives in disguise?   Melissa Raven
• [Ip-health] European Generics Medicines Assocation statement on ACTA   Manon Ress
• [Ip-health] BIO paper on incentives for innovation for neglected diseases   Manon Ress
• [Ip-health] Idea of the Day: Use Inducement Prizes to Stimulate Innovation   Manon Ress
• [Ip-health] Center for Public Integrity: pushing for drugs (report)   Manon Ress
• [Ip-health] Vietnam's IP Law question   Manon Ress
• [Ip-health] Innovative R&D Reform Agenda adopted at WHO   Sarah Rimmington
• [Ip-health] Brazilian Health Official on NPR, discusses HIV/AIDS treatment, CL   Sarah Rimmington
• [Ip-health] A record year for the Pharma lobby on Capitol Hill   Sarah Rimmington
• [Ip-health] Biotech still a sales star,,Global revenue up 12.5%, outstripping mainstream   Sarah Rimmington
• [Ip-health] The politics of polio   Sangeeta
• [Ip-health] SUNS: Meeting on patent law, as Secretariat issues report   Sangeeta
• [Ip-health] SUNS: US academic exposes IP maximalists' TRIPS-Plus Plus agenda   Sangeeta
• [Ip-health] SUNS: Patents committee begins work with usual North-South differences   Sangeeta
• [Ip-health] SUNS: Patent committee agrees on issues to re-start discussions   Sangeeta
• [Ip-health] Amendment to the Gilead-Ranbaxy License Agreement   Judit Rius Sanjuan
• [Ip-health] EMEA: High cost could affect drug accessibility   Judit Rius Sanjuan
• [Ip-health] EGA Report: Patent-related barriers to market entry for generic medicines in the EU   Judit Rius Sanjuan
• [Ip-health] The Counterfeit Treaty   Riaz K Tayob
• [Ip-health] High level meeting on AIDS - iWebcasting high-level meeting   Riaz K Tayob
• [Ip-health] Financial Times: Japan's Daiichi pays $4.6 billion for Ranbaxy   Miles Teg
• [Ip-health] House Ways and Means Democrats: USTR MUST STRIKE BALANCE - Question   Miles Teg
• [Ip-health] IFPMA press release on Alicia Greenidge   Jeffrey A. Williams
• [Ip-health] Email alert: June issue of the WHO Bulletin   bulletin
• [Ip-health] DFID Access to Medicines Research Network: public consultation   c-hughes@dfid.gov.uk
• [Ip-health] DFID Access to Medicines Research Network: further information   c-hughes@dfid.gov.uk
• [Ip-health] Tenovir Opposition in India - filed by Indian and Brazilian groups   gabriela@abiaids.org.br
• [Ip-health] The Counterfeit Treaty   james.love@keionline.org
• [Ip-health] NIH peer review changes   james.love@keionline.org
• [Ip-health] Pharma Anti-Counterfeiting Conference, 30th June-2nd July, London   mko
• [Ip-health] Paediatric nevirapine application rejected by Indian Patent Office   chan park
• [Ip-health] Opposition filed against Roche's Patent on Valganciclovir in India   chan park
• [Ip-health] Financial Times: Japan's Daiichi pays $4.6 billion for Ranbaxy   amit sen
• [Ip-health] Ranbaxy's takeover by Daiichi -- some facts to better understand the trend   amit sen
• [Ip-health] Abbott evergreening strategy at issue in Teva antitrust suit - WSJ   robert weissman
• [Ip-health] Pharma Anti-Counterfeiting Conference, 30th June-2nd July, London   robert weissman
• [Ip-health] GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers   robert weissman

Last message date: Mon Jun 30 12:56:02 2008
Archived on: Mon Jun 30 11:56:02 2008

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...